- Global Pharma News & Resources

Auto Injectors Market Status and Prospects 2022 to 2032 | By Sanofi, Pfizer, Inc, Mylan N.V., Novartis AG, Bayer AG

The global Auto Injectors Market size is anticipated to be worth US$ 23.9 billion by 2032, growing at a fantastic compound annual growth rate (CAGR) of 21.4% between 2022 and 2032. In 2022, the market was estimated to be worth roughly US$ 3.5 billion. The increasing frequency of several diseases, such as diabetes, anaphylaxis, and multiple sclerosis, among others, can be attributed to the growth of the Auto Injectors business. Furthermore, during the forecast period, the rise in medicine self-administration drives up demand for Auto Injectors.

Auto Injectors are medical devices that provide a dose of medication at a predetermined time. These devices reduce patients’ dependency on healthcare providers while also lowering needle-related injuries and needle fear, both of which are widespread among patients. Furthermore, when compared to traditional medicine delivery systems, Auto Injectors offer improved precision, ease of use, and less pain. They are preferred over other drug delivery systems because they give the medication in a painless and complete manner. Furthermore, the convenience factor is contributing to the good growth rate of the Auto Injectors market throughout the projection period.

A sample of this report is available upon request@

Furthermore, as chronic diseases become increasingly prevalent around the world, patients are looking for novel therapies and disease management options. Because traditional drug delivery methods are time-consuming, uncomfortable, and painful, many patients are turning to improved drug delivery systems like Auto Injectors to treat their illnesses and relieve symptoms. As a result, the auto injector market is predicted to expand quickly between 2022 and 2032.

“A swell in chronic diseases along with the rising demand for new and efficient drug delivery system is expected to propel the market growth of the Auto Injectors over the forecast period,” says an FMI analyst.  

Key Takeaways:

  • Rising trend of administrating medical products at home is facilitating market expansion.
  • Stringent regulatory approvals, premium pricing, and recall of the products may hinder the market growth.
  • Increasing regulatory approvals drive the market growth in the US
  • Auto Injectors market in Canada is likely to register 19.7% CAGR.
  • Pre-filled Auto Injectors will record a 21.6% CAGR over the forecast period.
  • By indication, anaphylaxis will maintain market domination over the assessment period.

Ask More About This Market’s Geographical Distribution Along With a Detailed Analysis of the Top Regions@

Competitive Landscape 

Becton, Dickinson and Company, Sanofi, Pfizer, Inc, Mylan N.V., Novartis AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc, Eli Lilly and Company, Teva Pharmaceutical, Merck KgaA, GlaxoSmithKline plc, Ypsomed, SHL Medical, Gerresheimer AG, Midas Pharma GmbH, Aptar Pharma, Solteam Medical, Stevanato Group, E3D, and West Pharmaceutical Services, Inc., among others are some of the major players in the Auto Injectors market profiled in the full version of the report.

Leading market players are focusing on releasing new products and approvals. These businesses also engage in mergers, acquisitions, partnerships, collaborations, and price reduction to expand their consumer base

More Insights into Auto Injectors Market Report

According to the latest FMI reports, based on region, the Auto Injectors market in Canada is expected to present remarkable growth over the assessment period. The market in this country is predicted to register a CAGR of 19.7% during 2022 to 2032. Growing health awareness, high prevalence of chronic diseases, and increasing popularity of Auto Injectors drive the market growth in this region. Apart from Canada, the US and Germany are also projected to undergo notable growth during this period of observation. While the US market is propelled by the growing cases of diabetes and anaphylaxis, the Auto Injectors market in Germany is driven by the inclination to minimize the risk of needle-related injuries and a preference for Auto Injectors.

Based on segmentation, on the basis of product type, the pre-filled auto injector segment is expected to dominate the market. In terms of indication, the anaphylaxis segment will account for the highest CAGR while, on the basis of distribution channel, online pharmacies will witness the highest sales.

Buy Complete Report@

Key Market Segments Covered in Auto-Injectors Industry Research

By Product:

  • Prefilled Auto-Injectors
  • Fillable Auto-Injectors

By Indication:

  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 30-May-2023